Observational Study of Efficiency of Cytoflavin, in Patients With Ischemic Stroke Not Receiving Reperfusion Therapy

NCT06514976 · clinicaltrials.gov ↗

RECRUITING

Status

562

Enrollment

INDUSTRY

Sponsor class

Conditions

Stroke, Acute
Stroke, Ischemic

Interventions

DRUG: Cytoflavin

Sponsor

POLYSAN Scientific & Technological Pharmaceutical Company